Recent research indicates that HER2-positive breast cancer consists of a diverse group of diseases, with HER2 overexpression leading to the loss of cell–cell junctions, making it more aggressive than luminal breast cancer cells [2,3,4]. The gene discussed is ERBB2; the disease is breast carcinoma.